2026 Guido Forni: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	88	1183	1072	44	41	367	23838
Medicine	88	13328	12544	508	487	368	23835

Overview

Guido Forni is affiliated with the University of Turin in Italy. Their research intersects the fields of Medicine and Mathematics, with a focus on Modeling and Simulation as a primary subfield. Additional subfields include Infectious Diseases, Public Health, Environmental and Occupational Health, Immunology, and Genetics.

The main topics of Guido Forni's work encompass:

COVID-19 epidemiological studies
Mathematical and Theoretical Epidemiology and Ecology Models
SARS-CoV-2 and COVID-19 Research
Immune responses and vaccinations
COVID-19 Clinical Research Studies
Mathematical Biology Tumor Growth
Evolution and Genetic Dynamics

Recent publications by Guido Forni include:

COVID-19 vaccines: where we stand and challenges ahead, 2021, Cell Death and Differentiation

Other frequently cited relevant works connected with this research area, though with different authorship, include:

A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world, 2020, CINECA IRIS Institutional Research Information System (Sant'Anna School of Advanced Studies)
Biological fluid dynamics of airborne COVID-19 infection, 2020, RENDICONTI LINCEI
Ten things we learned about COVID-19, 2020, Intensive Care Medicine
A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world, 2020, Mathematical Models and Methods in Applied Sciences

Guido Forni frequently collaborates with the following researchers:

Nicola Bellomo
Alberto Mantovani
Mark A. J. Chaplain
Giovanni Dosi
Damián Knopoff

Their research has appeared in several academic venues including:

Cell Death and Differentiation
CINECA IRIS Institutional Research Information System (Sant'Anna School of Advanced Studies)
RENDICONTI LINCEI
Mathematical Models and Methods in Applied Sciences
Intensive Care Medicine

Best Publications

A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

Giuliana Pelicci;Luisa Lanfrancone;Francesco Grignani;Jane McGlade

1673
Citations
Systemic spread is an early step in breast cancer.

Yves Hüsemann;Jochen B. Geigl;Falk Schubert;Piero Musiani

1479
Citations
The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

Emma Di Carlo;Guido Forni;PierLuigi Lollini;Mario P. Colombo

565
Citations
DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

Stefania Rovero;Augusto Amici;Emma Di Carlo;Roberto Bei

450
Citations
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

Cecilia Melani;Claudia Chiodoni;Guido Forni;Mario P. Colombo

431
Citations
Vaccines for tumour prevention

Pier-Luigi Lollini;Federica Cavallo;Patrizia Nanni;Guido Forni

416
Citations
Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

394
Citations
2011: the immune hallmarks of cancer

Federica Cavallo;Carla De Giovanni;Patrizia Nanni;Guido Forni

393
Citations
Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

Mario P. Colombo;Guido Forni

345
Citations
Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

Marta Coscia;Elena Quaglino;Manuela Iezzi;Claudia Curcio

311
Citations
Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development

Elisa Ciraolo;Manuela Iezzi;Romina Marone;Stefano Marengo

306
Citations
Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

Patrizia Nanni;Giordano Nicoletti;Carla De Giovanni;Lorena Landuzzi

297
Citations
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

254
Citations
Distribution of interferon-γ receptor in human tissues

Guido Valente;Laurence Ozmen;Francesco Novelli;Massimo Geuna

251
Citations
Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

Federica Cavallo;Mirella Giovarelli;Alberto Gulino;Alessandra Vacca

250
Citations
Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk.

Mario P. Colombo;Andrea Modesti;Giorgio Parmiani;Guido Forni

231
Citations
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphatically

Giorgio Cortesina;Antonella de Stefani;Mirella Giovarelli;Maria Grazia Barioglio

229
Citations
CYTOKINES, TUMOUR-CELL DEATH AND IMMUNOGENICITY : A QUESTION OF CHOICE

Piero Musiani;Andrea Modesti;Mirella Giovarelli;Federica Cavallo

223
Citations
Interferon‐γ receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death

Paola Bernabei;Eliana M. Coccia;Laura Rigamonti;Marita Bosticardo

214
Citations
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

Federica Cavallo;Paola Signorelli;Mirella Giovarelli;Piero Musiani

204
Citations
α-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

Yoshihiro Hayakawa;Stefania Rovero;Guido Forni;Mark J. Smyth

202
Citations

Frequent Co-Authors

Federica Cavallo University of Turin

Mirella Giovarelli University of Turin

Piero Musiani University of Chieti-Pescara

Andrea Modesti University of Rome Tor Vergata

Emma Di Carlo University of Chieti-Pescara

Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori

Santo Landolfo University of Turin

Patrizia Nanni University of Bologna

Francesco Novelli University of Turin

Angela Santoni Sapienza University of Rome

External Links

Personal website of Guido Forni

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can expand career opportunities. Many students pivot to nursing through online accelerated programs designed for non-nurses. These options provide a streamlined path to enter the healthcare profession quickly. If you’re looking for a faster route, 12-month accelerated nursing programs offer intensive study schedules that prepare you for the nursing workforce in just one year.

Entry into nursing can also be through Licensed Practical Nurse (LPN) programs, which vary in accessibility. Knowing which LPN programs are easiest to get into can help prospective students identify programs that align with their academic profiles and career goals.

For advanced practice roles, online nurse practitioner degrees provide a flexible pathway for professionals aiming to specialize and expand their clinical skills. Researching easiest online nurse practitioner programs can offer insights into programs with manageable admissions criteria without compromising quality.

Overall, combining Immunology knowledge with nursing credentials enhances versatility in healthcare careers. Exploring online accelerated nursing programs for non nurses is a great starting point for those aiming to bridge science and patient care effectively.